This paper argues the case for the legalization of addictive drugs such as marijuana, cocaine, and heroin. It maintains that there are no “market failures” which could justify a banning of these substances, and that, as in the earlier historical case of prohibition of alcohol, our present...

IDPC is pleased to announce that the IDPC Drug Policy Guide is now available in Georgian. This publication is a collaborative effort by a number of IDPC members and partners, and brings together global evidence and best practices on the design and implementation of drug policies and programmes...

The problems associated with the global drug trade are amongst the most challenging and intractable of all those facing policy-makers. The global drug prohibition system is widely acknowledged as a costly and counterproductive failure, not only presiding over a massive expansion of the problem...

Three months into the COVID-19 outbreak caused by a novel strain of coronavirus (SARS-CoV-2), the world is still in search of an effective therapeutic drug. Experimental drugs developed for other infections, such as Gilead's remdesivir, have been repurposed with unclear success. A recent small...

This publication addresses research questions related to an increase in the levels of access and utilization for four key interventions that have the potential to significantly reduce HIV infections among People Who Inject Drugs (PWID) and their sexual and injecting partners, and hence morbidity...

As the debate on drug policy and law reform gathers momentum on the international stage, the failings of the three UN drug control conventions (1961, 1971 and 1988) have come into stark relief. Criticisms of the global drug control regime established by the drug treaties have now entered the...

National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available -...

The opioid crisis is responsible for hundreds of thousands of deaths and trillions of dollars in costs. The secondary market for opioids contributes substantially to those numbers. Nevertheless, the welfare consequences of closing secondary market distribution remain ambiguous. Although shutting...